Bioventus (BVS) Total Debt (2020 - 2026)

Bioventus' Total Debt history runs 7 years deep, the most recent figure standing at $272.1 million for Q1 2026.

• Quarterly Total Debt fell 14.75% year-over-year to $272.1 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $272.1 million (down 14.75% YoY) and the FY2025 annual result came in at $294.0 million, down 12.42% from the prior year.
• Total Debt was $272.1 million for Q1 2026 at Bioventus, down from $294.0 million in the prior quarter.
• Across five years, Total Debt topped out at $445.6 million in Q2 2023 and bottomed at $272.1 million in Q1 2026.
• A 5-year average of $363.8 million and a median of $374.0 million in 2022 frame the typical range for Total Debt.
• Annual changes were most pronounced in 2022 — Total Debt surged 139.19% — and 2025, when it fell 18.42%.
• Bioventus' Total Debt stood at $418.1 million in 2022, then retreated by 5.55% to $394.8 million in 2023, then fell by 15.0% to $335.6 million in 2024, then decreased by 12.42% to $294.0 million in 2025, then declined by 7.44% to $272.1 million in 2026.
• Business Quant data shows BVS's Total Debt at $272.1 million in Q1 2026, $294.0 million in Q4 2025, and $322.6 million in Q3 2025.